FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/04/2026
Voltar para busca
Dado oficial do USPTO
FOKUS IQ QUIRIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 29, 30
Data de depósito
16/05/2024
Data de registro
26/08/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/08/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
DE
Examinador
GULIANO, ROBERT N
Unidade examinadora
L50
Localização atual
FILE REPOSITORY (FRANCONIA)
Descrição da marca
The mark consists of the wording "FOKUS IQ" with "FOKUS" in blue and "IQ" in orange with the "Q" extending into an orange and blue underline of the wording "FOKUS IQ" and containing the word "QUIRIS" in white within the underline.
Titulares e representantes
Titulares
Quiris Healthcare GmbH & Co. KG
Representantes
Shima Roy BAKER & MCKENZIE LLP
Classificação técnica
Classes Nice
Classe 5Classe 29Classe 30
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the treatment of cognitive disorders; pharmaceutical preparations for health care for the treatment of cognitive disorders; dietetic foods adapted for medical use; dietetic foods for cognitive diseasesin particular dementia; food supplements for medical purposes with a base of amino acidsvitamins and mineral supplements containingomega-3 fatty acidsomega-6 fatty acids and plant fibresincluding with added substances of animal and plant originindividually or in combinationincluded in this class; food supplementsnot for medical purposeswith a base of amino acidsvitaminsmineralstrace elementsomega-3 fatty acidsomega-6 fatty acids and plant fibresincluding with added substances of animal and plant originindividually or in combination; amino acid dietary supplements containingomega-3 fatty acid preparationsomega-6 fatty acid preparationsprotein preparationsvitamin preparationsnutritional salt preparations in the form of medicated granulespowdersemulsionsdrageescapsulesjuicescandydrops; nutritional supplement concentrates in the form of food supplements for medical purposesincluding in solid and liquid formincluding in powder form for own mixingin particular containing vegetable and/or animal protein and/or milk protein and/or collagen hydrolysates and/or vegetable hydrolysates and/or carbohydratesincluding with added vitaminsmineralsomega-3 fatty acidsomega-6 fatty acids and plant fibresdry fruit and sugar; dietary supplements for medical use based on albumen with added carbohydrates and vitamins; nutritional supplements in the form of beveragesgelsdrinking ampoulescapsulestablets and barsnot for medical purposesincluding in solid and liquid formincluding in powder form for own mixingwith added carbohydratesfibre and/or caffeinewith added vegetableanimal proteinmilk proteincollagen hydrolysatesvegetable hydrolysatesamino acidspeptidesvitaminsmineralsomega-3 fatty acidsomega-6 fatty acidsplant fibrescerealsdried fruit and/or sugar; nutritional supplements in the form of barscapsules and tabletsnot for medical purposesin solid form with a base of carbohydratesfibre and/or caffeineincluding with added vegetable and/or animal protein and/or milk protein and/or collagen hydrolysates and/or vegetable hydrolysatesamino acidspeptidesvitaminsmineralsomega-3 fatty acidsomega-6 fatty acidsplant fibresdry fruit and sugar; nutritional supplements in the form of beveragesgels and drinking ampoulesnot for medical purposesin liquid form with added carbohydratesfibre and/or caffeineincluding with added vegetable and/or animal protein and/or milk protein and/or collagen hydrolysates and/or vegetable hydrolysatesamino acidspeptidesvitaminsmineralsomega-3 fatty acidsomega-6 fatty acidsplant fibresdry fruit and sugar; nutritional supplements in the form of powder for own mixing for making non-alcoholic beveragesfor non-medical purposeswith a base of carbohydratesfibre and/or caffeineincluding with added vegetable and/or animal protein and/or milk protein and/or collagen hydrolysates and/or vegetable hydrolysatesamino acidspeptidesvitaminsmineralsomega-3 fatty acidsomega-6 fatty acidsplant fibrescerealsdried fruit and sugar
Classe 29
Pre-prepared non-dietetic meals consisting mainly of meatfishvegetablesnot for medical purposeswith added of proteinsfatsproteinsomega-3 fatty acidsomega-6 fatty acids; pre-prepared non-dietetic foods meals consisting mainly of meatfishvegetablesnot for medical purposeswith added carbohydrates
Classe 30
pre-prepared non-dietetic meals consisting mainly of ricecerealsnoodlesnot for medical purposeswith added proteinsfatsproteinsomega-3 fatty acidsomega-6 fatty acids; pre-prepared non-dietetic meals consisting mainly of ricecerealsnoodlesnot for medical purposeswith added carbohydrates
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/03/2026
FIMP
FINAL DISPOSITION PROCESSED
13/03/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
12/02/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
27/01/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
27/01/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
26/11/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
26/08/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/08/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
26/08/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/08/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/08/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
26/08/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
26/08/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/06/2025
PUBO
PUBLISHED FOR OPPOSITION
10/06/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/06/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/04/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/04/2025
GNRT
NON-FINAL ACTION E-MAILED
15/04/2025
CNRT
NON-FINAL ACTION WRITTEN
15/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
28/03/2025
RFNT
REFUSAL PROCESSED BY IB
05/01/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/12/2024
RFRR
REFUSAL PROCESSED BY MPU
18/12/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/12/2024
CNRT
NON-FINAL ACTION WRITTEN
05/12/2024
DOCK
ASSIGNED TO EXAMINER
02/12/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/09/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/09/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
29/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace FOKUS IQ QUIRIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.